Featured story

Blackrock Neurotech’s Marcus Gerhardt: “An inflection point for brain-computer interfaces”

Marcus Gerhardt, CEO of Blackrock Neurotech, speaks about the “BCI value inflection point” on the Times’ podcast, Danny in the Valley.

Listen to the podcast

Insights

Oct. 10, 2021

Why the number of people needing mental health support is all 100% of the world’s population

Spotlight

Jul. 20, 2021

Stigma Podcast

Listen to the podcast

Feb. 23, 2023

Blackrock Neurotech’s Marcus Gerhardt: “An inflection point for brain-computer interfaces”

Listen to the podcast

News

Nov. 08, 2023

Precision Neuroscience Successfully Acquires Facility for Manufacturing Brain Implants

Jul. 03, 2023

OpenBCI CEO Speaks at TED2023: Neurotech Tools for Augmenting the Mind

Jun. 26, 2023

Delix Announces Completion of 1st Cohort Dosing in Lead Candidate, DLX-001

Jun. 12, 2023

Precision Neuroscience begins First-in-Human trial for Electrophysiological Mapping

May. 11, 2023

Small Pharma’s Phase 2a Follow-up: DMT Appears Effective for Depression 6 Months After Dosing

May. 11, 2023

Blackrock Neurotech Founders Announced as Finalists in EY’s Entrepreneur of the Year Award

Feb. 06, 2023

Alto Neuroscience Announces $60 Million in Additional Financing

Nov. 17, 2022

Blackrock Neurotech Reveals Latest Innovation in Next-Gen BCI

Aug. 19, 2022

Blackrock BCI Pioneer Sets Record for Total Time Implanted

Aug. 01, 2022

iLoF secures €4.89 million to accelerate personalised drug discovery

Mar. 24, 2022

Alena has successfully closed a $2.7m Seed round

Feb. 23, 2022

Thought-To-Text Typing Hits 90 Characters/Minute With 94% Accuracy

Feb. 05, 2022

Ex-Neuralink President Invests in Competing Brain Startup

Jan. 12, 2022

CereGate advances in clinical development and secures financing

Feb. 21, 2023

re.Mind invests in Precision Neuroscience’s Series B

Social

@ ·

now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter